Molecular Profiling of Renal Medullary Carcinoma Reveals TROP2 as a Potential Therapeutic Target
In a groundbreaking collaborative effort, researchers at The University of Texas MD Anderson Cancer Center, in partnership with biotechnology firm BostonGene, have achieved a significant...
















